MX2013005725A - Composicion para el uso en la prevencion y/o tratamiento de condiciones de la piel y enfermedades de la piel. - Google Patents

Composicion para el uso en la prevencion y/o tratamiento de condiciones de la piel y enfermedades de la piel.

Info

Publication number
MX2013005725A
MX2013005725A MX2013005725A MX2013005725A MX2013005725A MX 2013005725 A MX2013005725 A MX 2013005725A MX 2013005725 A MX2013005725 A MX 2013005725A MX 2013005725 A MX2013005725 A MX 2013005725A MX 2013005725 A MX2013005725 A MX 2013005725A
Authority
MX
Mexico
Prior art keywords
skin diseases
treating skin
oligosaccharide composition
composition
oligosaccharide
Prior art date
Application number
MX2013005725A
Other languages
English (en)
Other versions
MX341684B (es
Inventor
Norbert Sprenger
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43660944&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2013005725(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2013005725A publication Critical patent/MX2013005725A/es
Publication of MX341684B publication Critical patent/MX341684B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Abstract

La invención divulga una composición que comprende al menos una N-acetil-lactosamina, al menos un oligosacárido sialilado y al menos un oligosacárido fucosilado, para uso en la prevención y/o tratamiento de condiciones de la piel y enfermedades de la piel. Preferentemente dicha composición es una fórmula infantil de inicio. Dicha enfermedad de la piel es en particular dermatitis atópica.
MX2013005725A 2010-11-23 2011-11-21 Composicion para el uso en la prevencion y/o tratamiento de condiciones de la piel y enfermedades de la piel. MX341684B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10192227A EP2465507A1 (en) 2010-11-23 2010-11-23 Oligosaccharide composition for treating skin diseases
PCT/EP2011/070561 WO2012076321A1 (en) 2010-11-23 2011-11-21 Oligosaccharide composition for treating skin diseases

Publications (2)

Publication Number Publication Date
MX2013005725A true MX2013005725A (es) 2013-07-03
MX341684B MX341684B (es) 2016-08-30

Family

ID=43660944

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013005725A MX341684B (es) 2010-11-23 2011-11-21 Composicion para el uso en la prevencion y/o tratamiento de condiciones de la piel y enfermedades de la piel.

Country Status (18)

Country Link
US (1) US8771674B2 (es)
EP (2) EP2465507A1 (es)
CN (1) CN104302297A (es)
AU (1) AU2011340880B2 (es)
BR (1) BR112013011730A2 (es)
CA (1) CA2818011A1 (es)
CL (1) CL2013001436A1 (es)
ES (1) ES2616957T3 (es)
IL (1) IL226049A0 (es)
MX (1) MX341684B (es)
MY (1) MY160894A (es)
PH (1) PH12013500892A1 (es)
PL (1) PL2643004T3 (es)
RU (1) RU2609838C2 (es)
SG (1) SG190079A1 (es)
TW (1) TW201300111A (es)
WO (1) WO2012076321A1 (es)
ZA (1) ZA201304638B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2454948A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2465509A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating acute respiratory tract infections
SG191394A1 (en) 2010-12-31 2013-08-30 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
US9539269B2 (en) 2010-12-31 2017-01-10 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
WO2012177556A2 (en) 2011-06-20 2012-12-27 H.J. Heinz Company Probiotic compositions and methods
ES2657744T3 (es) 2011-07-22 2018-03-06 Abbott Laboratories Galactoligosacáridos para prevenir lesiones y/o promover la curación del tracto gastrointestinal
EP2750523A1 (en) 2011-08-29 2014-07-09 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
EP2656862A1 (en) * 2012-04-24 2013-10-30 The Procter & Gamble Company Substrate comprising one or more human milk oligosaccharides and disposable absorbent article comprising the substrate
EP2857410A1 (en) * 2013-10-04 2015-04-08 Jennewein Biotechnologie GmbH Process for purification of 2´-fucosyllactose using simulated moving bed chromatography
WO2015071131A1 (en) * 2013-11-15 2015-05-21 Nestec S.A. Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by c-section
US10568896B2 (en) 2013-11-19 2020-02-25 Abbott Laboratories Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides
WO2015085549A1 (en) * 2013-12-12 2015-06-18 Nestec S.A. An age-tailored nutrition system for an infant
EP2885977A1 (en) * 2013-12-19 2015-06-24 Agriculture and Food Development Authority (TEAGASC) An oligosaccharide-enriched composition having immune-modulatory and anti-adhesion properties
US10695358B2 (en) * 2013-12-20 2020-06-30 Abbott Laboratories Oral rehydration composition with oligosaccharides
SG11201608248YA (en) * 2014-04-08 2016-10-28 Abbott Lab Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides
CN107001528A (zh) 2014-07-09 2017-08-01 米德瑞（美国）有限公司 低聚糖组合物及其制备方法
CN107249611A (zh) * 2014-10-24 2017-10-13 进化生物系统股份有限公司 活化的双歧杆菌及其应用方法
CA2975095A1 (en) 2015-01-26 2016-08-04 Cadena Bio, Inc. Oligosaccharide compositions for use as animal feed and methods of producing thereof
CN107846957A (zh) * 2015-03-05 2018-03-27 雀巢产品技术援助有限公司 用于改善婴儿或幼儿粪便稠度或频率的组合物
CN116270718A (zh) 2015-04-23 2023-06-23 Dsm营养产品有限责任公司 聚糖治疗剂和治疗方法
US10034937B2 (en) 2015-12-04 2018-07-31 Mead Johnson Nutrition Company Synergistic nutritional compositions and uses thereof
CN108495560A (zh) * 2016-01-26 2018-09-04 雀巢产品技术援助有限公司 用于预防和/或治疗皮肤病症和皮肤疾病的组合物
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
WO2017173241A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
CA3043748A1 (en) 2016-11-23 2018-05-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
EP3672600A4 (en) 2017-08-21 2021-05-19 Glycom A/S SYNTHETIC COMPOSITION TO REDUCE ALLERGY SYMPTOMS
CN112040973B (zh) 2018-04-25 2022-03-29 合生元（广州）健康产品有限公司 用作药物的骨桥蛋白和2’-岩藻糖基乳糖的组合
SG11202011188SA (en) * 2018-05-11 2020-12-30 Forte Subsidiary Inc Compositions for the treatment of skin conditions
CN108935697A (zh) * 2018-09-11 2018-12-07 内蒙古伊利实业集团股份有限公司 一种用于预防小儿湿疹的营养组合物
BE1027078A9 (nl) * 2019-02-25 2020-09-28 Nutribam Bvba Samenstelling, voedingssupplement en werkwijze voor het ondersteunen en/of verbeteren van de darmgezondheid
WO2020174386A1 (en) 2019-02-25 2020-09-03 Nutribam Bvba Composition, food supplement and method for supporting and/or improving intestinal health
ES1240969Y (es) * 2019-09-18 2020-07-30 Jennewein Biotechnologie Gmbh Composiciones de cereales que contienen oligosacaridos de la leche humana

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016449A1 (en) 1990-04-16 1991-10-31 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5545553A (en) 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
DE19701382A1 (de) * 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
ES2314461T3 (es) * 2003-10-24 2009-03-16 N.V. Nutricia Composicion simbiotica para bebes.
US7893041B2 (en) * 2003-12-05 2011-02-22 Children's Hospital Medical Center Oligosaccharide compositions and use thereof in the treatment of infection
EP1634599A1 (en) * 2004-08-20 2006-03-15 N.V. Nutricia Iimmune stimulatory infant nutrition
KR20080019059A (ko) * 2005-06-24 2008-02-29 칼피스가부시키가이샤 표피세포 분화 및 각화 촉진제, 및 표피 각화 촉진용기능성 음식품
CN101432007A (zh) * 2006-03-07 2009-05-13 雀巢产品技术援助有限公司 合益素混合物
CA2883256A1 (en) * 2006-03-10 2007-09-20 N.V. Nutricia Use of non-digestible saccharides for strengthening the immune system
WO2007114683A1 (en) * 2006-03-30 2007-10-11 N.V. Nutricia Milk oligosaccharides for stimulating the immune system
EP1974743A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
EP2127661A1 (en) * 2008-05-27 2009-12-02 Nestec S.A. Probiotics to improve gut microbiotica
WO2010002241A1 (en) * 2008-06-30 2010-01-07 N.V. Nutricia Nutritional composition for infants delivered via caesarean section

Also Published As

Publication number Publication date
RU2013128594A (ru) 2014-12-27
ES2616957T3 (es) 2017-06-14
WO2012076321A1 (en) 2012-06-14
CA2818011A1 (en) 2012-06-14
US8771674B2 (en) 2014-07-08
CN104302297A (zh) 2015-01-21
TW201300111A (zh) 2013-01-01
CL2013001436A1 (es) 2014-02-14
EP2465507A1 (en) 2012-06-20
SG190079A1 (en) 2013-06-28
EP2643004A1 (en) 2013-10-02
MX341684B (es) 2016-08-30
BR112013011730A2 (pt) 2016-08-16
AU2011340880B2 (en) 2017-03-02
EP2643004B1 (en) 2016-12-21
MY160894A (en) 2017-03-31
PL2643004T3 (pl) 2017-07-31
AU2011340880A1 (en) 2013-05-23
IL226049A0 (en) 2013-06-27
ZA201304638B (en) 2016-02-24
PH12013500892A1 (en) 2013-07-01
RU2609838C2 (ru) 2017-02-06
US20130251682A1 (en) 2013-09-26

Similar Documents

Publication Publication Date Title
MY160894A (en) Oligosaccharide composition for treating skin diseases
MX343322B (es) Composicion que comprende proteinas hidrolizadas y oligosacaridos para tratar enfermedades de la piel.
MX2012000034A (es) Metodos para el tratamiento o la prevencion de la fatiga.
MX2013004699A (es) Combinaciones farmaceuticas para el tratamiento de trastornos metabolicos.
MX2016006221A (es) Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños.
WO2013169864A3 (en) TETRAHYDRO[1,8]NAPHTHYRIDINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORƴ AND THE TREATMENT OF DISEASE
PA8778101A1 (es) Metodos y composiciones para tratar y monitorear el tratamiento de trastornos asociados con il-13
MX343321B (es) Composicion para ser usada en la prevencion de infecciones agudas del tracto respiratorio y/o para aliviar los sintomas de dichas infecciones.
WO2010083239A3 (en) Therapeutic modulation of vaginal epithelium boundary lubrication
WO2011014255A8 (en) Treatment of crohn's disease with laquinimod
NZ727304A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
WO2010071826A3 (en) Methods for treating osteoclast-related disease, compounds and compositions thereof
WO2010151755A3 (en) TREATMENT OF INFLAMMATORY DISEASES USING miR-124
WO2009068659A3 (en) Novel disease treatment by predicting drug association
MX2014005209A (es) Un medicamento para tratar la enfermedad del ojo anterior que comprende rebamipida y un agente de retencion de lagrimas.
MY150931A (en) Substituted oxazolidinones and their use
EP2274411A4 (en) XANTHOHUMOL COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES OR CONDITIONS
WO2011044523A3 (en) Compositions and methods for treating obesity
IN2014CN03333A (es)
EP2005194A4 (en) HEMOGLOBIN-BASED METHODS FOR PROPHYLAXIS, DIAGNOSTIC OR BZW. TREATMENT OF NETWORK DISEASES
PH12019501439A1 (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
MX2015005733A (es) Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
WO2011011706A3 (en) Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents
WO2010042212A3 (en) Methods for treating or preventing pain using spicamycin derivatives
CR20110438A (es) Icam 1 soluble como biomarcador para predicción de respuesta terapéutica

Legal Events

Date Code Title Description
FG Grant or registration